Unknown

Dataset Information

0

Clinical observations and a ealthcare ailure ode and ffect nalysis to identify vulnerabilities in the security and accounting of medications in Ontario hospitals: a study protocol.


ABSTRACT: INTRODUCTION:An increasing number of opioids and other controlled substances are being stolen from healthcare facilities, diverting medications from their intended medical use to be used or sold illicitly. Many incidents of medication loss from Canadian hospitals are reported as unexplained losses. Together, this suggests not only that vulnerabilities for diversion exist within current medication-use processes (MUPs), but that hospitals lack robust mechanisms to accurately track and account for discrepancies and loss in inventory. There is a paucity of primary research investigating vulnerabilities in the security and accounting of medications across hospital processes. The purpose of this study is to map hospital MUPs, systematically identify risks for diversion or unintentional loss and proactively assess opportunities for improvements to medication accounting and security. METHODS AND ANALYSIS:We will conduct human factors-informed clinical observations and a Healthcare Failure Mode and Effect Analysis (HFMEA). We will observe hospital personnel in the intensive care unit, emergency department and inpatient pharmacy in two hospitals in Ontario, Canada. Observations will capture how participants complete tasks, as well as gather contextual information about the environment, technologies and processes. A multidisciplinary team will complete an HFMEA to map process flow diagrams for the MUPs in the observed clinical units, identify and prioritise potential methods of medication loss (failure modes) and describe mechanisms or actions to prevent, detect and trace medication loss. ETHICS AND DISSEMINATION:We received province-wide research ethics approval via Clinical Trials Ontario Streamlined Research Review System, and site-specific approvals from each participating hospital. The results from this study will be presented at conferences and meetings, as well as published in peer-reviewed journals. The findings will be shared with hospitals; professional, regulatory and accreditation organisations; patient safety and healthcare quality organisations and equipment and drug manufacturers.

SUBMITTER: de Vries M 

PROVIDER: S-EPMC6609086 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC5116247 | BioStudies
1000-01-01 | S-EPMC3869635 | BioStudies
2019-01-01 | S-EPMC6398683 | BioStudies
2014-01-01 | S-EPMC4504250 | BioStudies
2020-01-01 | S-EPMC7313163 | BioStudies
2017-01-01 | S-EPMC5774985 | BioStudies
2019-01-01 | S-EPMC6625068 | BioStudies
2015-01-01 | S-EPMC4591852 | BioStudies
2020-01-01 | S-EPMC7141666 | BioStudies
2019-01-01 | S-EPMC6441233 | BioStudies